Preclinical Development of Inhalable D-Cycloserine and Ethionamide to Overcome Pharmacokinetic Interaction and Enhance Efficacy Against Mycobacterium Tuberculosis
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00099-19
Full Text
Open PDFAbstract
Available in full text
Date
April 8, 2019
Authors
Publisher
American Society for Microbiology